Drug name - Acuvail

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7842714 ALLERGAN Ketorolac tromethamine compositions for treating ocular pain
Aug, 2029

(6 years from now)

CN102014869A ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Sep, 2015

(7 years ago)

CN103976943B ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

CN103976943A ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

CN102497856B ALLERGAN For Treating Or Prevention Eye Pain Of Ketorolac Tromethamine Composition
Aug, 2030

(7 years from now)

CN102497856A ALLERGAN Ketorolac Tromethamine Composition For Treating Or Preventing Eye Pain
Aug, 2030

(7 years from now)

IN286644B ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

IN201006461P1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

EP2257275A2 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

EP2257275B1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

EP2446878B1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

EP2446878A1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

EP2473157A1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Aug, 2030

(7 years from now)

EP2473157B1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Aug, 2030

(7 years from now)

EP2555770B1 ALLERGAN Ketorolac Compositions For Corneal Wound Healing
Apr, 2031

(8 years from now)

EP2555770A1 ALLERGAN Ketorolac Compositions For Corneal Wound Healing
Apr, 2031

(8 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8992952 ALLERGAN Compositions for delivery of therapeutics into the eyes and methods for making and using same Aug, 2024

(1 year, 10 months from now)

US9192571 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain Mar, 2028

(5 years from now)

US8512717 ALLERGAN Compositions for delivery of therapeutics into the eyes and methods for making and using same Mar, 2028

(5 years from now)

Drugs and Companies using KETOROLAC TROMETHAMINE ingredient

Treatment: NA

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.45% SOLUTION/DROPS;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.